文献速递骨质疏松与钙磷/甲状旁腺肥胖与代谢综合征

无机磷添加剂对健康人矿物质代谢及心血管代谢风险因素的急性影响

Acute Effects of an Inorganic Phosphorus Additive on Mineral Metabolism and Cardiometabolic Risk Factors in Healthy Subjects.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

本研究为双盲安慰剂对照交叉试验,29名健康受试者单次口服700 mg磷(NaH2PO4)或钠调整安慰剂并进食测试餐。结果显示口服磷使餐后血磷升高持续8小时,尿磷增加、肾小管磷重吸收减少、尿钙降低、PTH释放增加,但FGF23水平及餐后血糖、胰岛素、血脂均无显著变化。

要点

  • 健康人单次口服700 mg磷可致餐后血磷升高持续8小时
  • 口服磷负荷刺激PTH释放、降低尿钙、减少肾小管磷重吸收
  • FGF23水平及餐后血糖、胰岛素、血脂未见显著影响

核心结论

  • 健康受试者口服磷负荷可致餐后循环磷水平升高数小时,尽管快速稳态代偿反应发生。
  • FGF23水平及餐后食物反应未受口服磷负荷影响。

研究设计与样本

  • 双盲安慰剂对照交叉研究,纳入29名来自一般社区的健康男性和女性参与者。
  • 单次给予700 mg磷(NaH2PO4)或钠调整安慰剂,并结合测试餐。

主要发现

  • 与安慰剂相比,口服磷增加血浆磷水平,并在后续8小时内保持升高(480分钟时:1.31 vs 1.16 mmol/l;P < 0.001)。
  • 口服磷增加尿磷(iAUC0-480 789 vs 95 mmol/mmol;P < 0.001),降低肾小管磷重吸收(iAUC0-480 -31.5 vs -6.2;P < 0.001)。
  • 口服磷降低尿钙(iAUC0-240 30.6 vs 53.0 mmol/mmol;P = 0.009),刺激甲状旁腺激素释放(iAUC0-480 2212 vs 768 ng/l;P < 0.001)。
  • FGF23水平未变化,餐后血糖、胰岛素和血脂与安慰剂相比无实质性影响。

临床怎么用

  • 健康人摄入无机磷添加剂后应关注餐后血磷升高及PTH反应。
  • 短期口服磷负荷对FGF23及餐后血糖、胰岛素、血脂无显著影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Hyperphosphatemia and high levels of fibroblast growth factor 23 (FGF23) are risk factors for cardiovascular events in patients with chronic kidney diseases. However, the impact of an inorganic phosphorus additive in healthy people is largely unknown. OBJECTIVE: We aimed to investigate the acute effect of excessive dietary phosphorus administered as sodium dihydrogen phosphate on the postprandial levels of Pi and FGF23 and the response to food. METHODS: This study was a double-blind placebo-controlled crossover study with 29 healthy male and female participants from the general community who were administered a single dose of either 700 mg phosphorus (NaH2PO4) or a sodium-adjusted placebo in combination with a test meal. Postprandial plasma levels of Pi and FGF23 were measured. RESULTS: Compared with placebo, oral phosphorus increased the plasma Pi level, which remained elevated during the ensuing 8 hours (at 480 minutes: 1.31 vs 1.16 mmol/l; P < 0.001), increased urinary Pi (iAUC0-480 789 vs 95 mmol/mmol; P < 0.001), reduced tubular Pi reabsorption (iAUC0-480 -31.5 vs -6.2; P < 0.001), decreased urinary calcium (iAUC0-240 30.6 vs 53.0 mmol/mmol; P = 0.009), and stimulated the release of parathyroid hormone (iAUC0-480 2212 vs 768 ng/l; P < 0.001). However, the FGF23 levels did not change. Postprandial levels of glucose, insulin, and lipids were not substantially affected by phosphorus vs placebo. CONCLUSION: An oral phosphorus load can induce elevated postprandial levels of circulating Pi for hours in healthy subjects, despite rapid homeostatic counterreactions. FGF23 levels and the postprandial response to food were not affected.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Volk C, Schmidt B, Brandsch C, et al. Acute Effects of an Inorganic Phosphorus Additive on Mineral Metabolism and Cardiometabolic Risk Factors in Healthy Subjects. J Clin Endocrinol Metab. 2022. PMID: 34448875. doi:10.1210/clinem/dgab635

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。